2020 American Transplant Congress
Deleterious Effect of Intravenous Steroids on Bone Mineral Density in Patients Treated for Borderline Rejection of the Renal Allograft
Transplant Nephrology, Mayo Clinic, Jacksonville, FL
*Purpose: Subclinical rejection of the renal allograft is known to increase the risk of developing interstitial fibrosis and tubular atrophy which ultimately translates into shortening…2020 American Transplant Congress
Clinicopathological Evaluation of Long-Term Survivor More Than 10 Years after Living Kidney Transplant with Corticosteroid Early Withdrawal Protocol
*Purpose: We have previously reported that favorable short-term outcomes of kidney recipients were achieved by corticosteroid early withdrawal protocol (CSEW) compared to the conventional protocol…2020 American Transplant Congress
Glucocorticoid-Induced Osteoporosis in Lung Transplant Patients
Department of Pharmacy, University of Chicago Medicine, Chicago, IL
*Purpose: Although vital for preventing rejection, glucocorticoids contribute to post-operative morbidity, including osteoporosis. The primary purpose of this study was to identify the occurrence of…2018 American Transplant Congress
Progression of Vertebral Bone Disease among Kidney Allograft Recipients on Steroid Maintenance
BackgroundOsteoporosis has been recognized as a significant cause of morbidity post kidney transplantation. We aimed to evaluate the prevalence of osteoporosis at one year post…2017 American Transplant Congress
Tenofovir Use Is Not Associated with Reduced Bone Density or Fractures in Liver Transplant Recipients.
University of Minnesota, Minneapolis, MN
BackgroundTenofovir disproxil fumarate (TDF) and reduced bone density in the HIV population is well-documented. The effect of TDF use on bone density in patients who…
American Transplant Congress abstracts